Disclosed herein are methods of making ceragenin compounds for treating, preventing, or diagnosing diseases, disorders, or conditions associated with bacterial or viral infections, cancer, inflammation, and osteogenesis. Ceragenin compounds display broad spectrum antibacterial activity utilizing a m
Disclosed herein are methods of making ceragenin compounds for treating, preventing, or diagnosing diseases, disorders, or conditions associated with bacterial or viral infections, cancer, inflammation, and osteogenesis. Ceragenin compounds display broad spectrum antibacterial activity utilizing a mode of action similar to antimicrobial peptides, but without the high synthesis costs and susceptibility to proteolytic degradation. Ceragenin compounds reproduce the amphiphilic morphology found in many antimicrobial peptides and display potent and diverse biological activities, including anti-bacterial, anti-cancer, anti -inflammatory, bone growth promotion, and wound healing promotion.
대표청구항▼
1. A method of making a compound of Formula (I) or (II), comprising the steps of: (a) reacting a compound of Formula (1) and R1R2—NH to form a compound of Formula (2): (b) reacting a compound of Formula (2) with an compound of Formula (A), in the presence of acid and a phase transfer catalyst, to
1. A method of making a compound of Formula (I) or (II), comprising the steps of: (a) reacting a compound of Formula (1) and R1R2—NH to form a compound of Formula (2): (b) reacting a compound of Formula (2) with an compound of Formula (A), in the presence of acid and a phase transfer catalyst, to form a compound of Formula (3): and (c) subjecting a compound of Formula (3) to reducing conditions to form a compound of Formula (I): or a compound of Formula (II): wherein:R1 and R2 are independently selected from the group consisting of hydrogen, optionally substituted C1-C24 alkyl, optionally substituted C2-C24 alkenyl, optionally substituted C2-C24 alkynyl, optionally substituted C6 or C10 aryl, optionally substituted 5 to 10 membered heteroaryl, optionally substituted 5 to 10 membered heterocyclyl, optionally substituted C7-13 aralkyl, optionally substituted (5 to 10 membered heteroaryl)-C1-C6 alkyl, optionally substituted C3-10 carbocyclyl, optionally substituted C4-10 (carbocyclyl)alkyl, optionally substituted (5 to 10 membered heterocyclyl)-C1-C6 alkyl, optionally substituted amido, and a suitable amine protecting group; andR3 is selected from the group consisting of optionally substituted C1-C24 alkyl, optionally substituted C2-C24 alkenyl, optionally substituted C2-C24 alkynyl, optionally substituted 5 to 10 membered heterocyclyl, optionally substituted C7-13 aralkyl, optionally substituted (5 to 10 membered heteroaryl)-C1-C6 alkyl, optionally substituted C3-10 carbocyclyl, optionally substituted C4-10 (carbocyclyl)alkyl, and optionally substituted (5 to 10 membered heterocyclyl)-C1-C6 alkyl. 2. The method of claim 1, wherein R1 and R2, together with the atoms to which they are attached form an optionally substituted 5 to 10 membered heterocyclyl ring. 3. A method of making a compound of Formula (I) or Formula (II), comprising the steps of: (a) subjecting a compound of Formula (2) to reducing conditions to form a compound of Formula (2a): (b) reacting a compound of Formula (2a) with an compound of Formula (A), in the presence of acid and a phase transfer catalyst, to form a compound of Formula (3): and (c) subjecting a compound of Formula (3) to reducing conditions to form a compound of Formula (I): or a compound of Formula (II): wherein:R1 and R2 are independently selected from the group consisting of hydrogen, optionally substituted C1-C24 alkyl, optionally substituted C2-C24 alkenyl, optionally substituted C2-C24 alkynyl, optionally substituted C6 or C10 aryl, optionally substituted 5 to 10 membered heteroaryl, optionally substituted 5 to 10 membered heterocyclyl, optionally substituted C7-13 aralkyl, optionally substituted (5 to 10 membered heteroaryl)-C1-C6 alkyl, optionally substituted C3-10 carbocyclyl, optionally substituted C4-10 (carbocyclyl)alkyl, optionally substituted (5 to 10 membered heterocyclyl)-C1-C6 alkyl, optionally substituted amido, and a suitable amine protecting group; andR3 is selected from the group consisting of optionally substituted C1-C24 alkyl, optionally substituted C2-C24 alkenyl, optionally substituted C2-C24 alkynyl, optionally substituted 5 to 10 membered heterocyclyl, optionally substituted C7-13 aralkyl, optionally substituted (5 to 10 membered heteroaryl)-C1-C6 alkyl, optionally substituted C3-10 carbocyclyl, optionally substituted C4-10 (carbocyclyl)alkyl, and optionally substituted (5 to 10 membered heterocyclyl)-C1-C6 alkyl. 4. The method of claim 3, wherein R1 and R2, together with the atoms to which they are attached form an optionally substituted 5 to 10 membered heterocyclyl ring. 5. The method of claim 3, wherein R1 is hydrogen and R2 is selected from the group consisting of hydrogen, optionally substituted C1-C24 alkyl, optionally substituted C2-C24 alkenyl, optionally substituted C2-C24 alkynyl, optionally substituted C6 or C10 aryl, optionally substituted 5 to 10 membered heteroaryl, optionally substituted 5 to 10 membered heterocyclyl, optionally substituted C7-13 aralkyl, optionally substituted (5 to 10 membered heteroaryl)-C1-C6 alkyl, optionally substituted C3-10 carbocyclyl, optionally substituted C4-10 (carbocyclyl)alkyl, optionally substituted (5 to 10 membered heterocyclyl)-C1-C6 alkyl, and a suitable amine protecting group. 6. The method of claim 3, wherein R1 is hydrogen and R2 is selected from the group consisting of optionally substituted C1-C24 alkyl, optionally substituted C2-C24 alkenyl, optionally substituted C2-C24 alkynyl, optionally substituted C6 or C10 aryl, optionally substituted 5 to 10 membered heteroaryl, optionally substituted 5 to 10 membered heterocyclyl, optionally substituted C7-13 aralkyl, optionally substituted (5 to 10 membered heteroaryl)-C1-C6 alkyl, optionally substituted C3-10 carbocyclyl, optionally substituted C4-10 (carbocyclyl)alkyl, and optionally substituted (5 to 10 membered heterocyclyl)-C1-C6 alkyl. 7. The method of claim 3, wherein R1 is hydrogen and R2 is optionally substituted C1 -C24 alkyl. 8. The method of claim 3, wherein the compound of Formula (I) is selected from the group consisting of: 9. The method of claim 3, wherein the compound of Formula (II) is selected from the group consisting of: and salts thereof. 10. The method of claim 3, wherein the method is carried out in one or more solvents selected from the group consisting of water, acetic acid, formic acid, hydrochloric acid, hydrobromic acid, DMF, DMSO, DCM, NMP, chloroform, THF, 2-methyl-THF, benzene, toluene, trifluorotoluene, dioxane, methanol, ethanol, ethyl acetate, acetone, or any combination thereof. 11. The method of claim 3, wherein the method is carried out at a temperature of at least at least 0° C., at least 10° C., at least 20° C., at least 30° C., at least 40° C., at least 50° C., at least 60° C., at least 70° C., at least 80° C., at least 90° C., at least 100° C., at least 110° C., at least 120° C., at least 130° C., at least 140° C., at least 150° C., at least 160° C., at least 170° C., or at least 180° C. 12. The method of claim 3, wherein the method is accomplished in less than 36 hours, less than 35 hours, less than 34 hours, less than 33 hours, less than 32 hours, less than 31 hours, less than 30 hours, less than 29 hours, less than 28 hours, less than 27 hours, less than 26 hours, less than 25 hours, less than 24 hours, less than 23 hours, less than 22 hours, less than 21 hours, less than 20 hours, less than 19 hours, less than 18 hours, less than 17 hours, less than 16 hours, less than 15 hours, less than 14 hours, less than 13 hours, less than 12 hours, less than 11 hours, less than 10 hours, less than 9 hours, less than 8 hours, less than 7 hours, less than 6 hours, less than 5 hours, less than 4 hours, less than 3 hours, less than 2 hours, or less than 1 hour. 13. The method of claim 3, wherein the method provides at least one gram, at least 10 grams, and least 100 grams, at least 500 grams, at least one kilogram, at least 10 kilograms, at least 50 kilograms, at least 100 kilogram, or at least 500 kilograms, of a compound of Formula (I) or a compound of Formula (II). 14. The method of claim 3, wherein the method is substantially performed at ambient pressure. 15. The method of claim 3, wherein the method does not deliberately exclude the presence of oxygen. 16. The method of claim 3, wherein the method is substantially performed in a non-oxygen-containing atmosphere. 17. The method of claim 3, wherein the method is performed with a mixing rate of at least 1 rpm, at least 10 rpms, at least 20 rpms, at least 30 rpms, at least 40 rpms, at least 50 rpms, at least 60 rpms, at least 70 rpms, at least 80 rpms, at least 90 rpms, at least 100 rpms, at least 110 rpms, at least 120 rpms, at least 200 rpms, or at least 500 rpms.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (42)
Beus, Chad S.; Savage, Paul B., Animal feed including cationic cholesterol additive and related methods.
Hansen Richard E. (Roswell GA) Rippl Carl G. (Woodstock GA) Midkiff David G. (Alpharetta GA) Neuwirth Joseph G. (Cumming GA), Antimicrobial absorbent food pad.
Hibbs, Michael; Altman, Susan J.; Jones, Howland D. T.; Savage, Paul B., Biofouling-resistant ceragenin-modified materials and structures for water treatment.
Dunn Michael J. ; Bergren Michael S. ; Hardee Gregory E. ; Shephard Kenneth Paul ; Chao Robert S. ; Havens Jeffrey L., Crystalline ceftiofur free acid.
Laurencin Cato T. (Somerville MA) Lucas Paul A. (Macon GA) Syftestad Glenn T. (Sacramento CA) Domb Abraham (Baltimore MD) Glowacki Julianne (Jamaica Plan MA) Langer Robert S. (Newton MA), Delivery system for controlled release of bioactive factors.
Di Domenico Edward D. (Anoka MN) Hobot Christopher M. (Tonka Bay MN) Stokes Kenneth B. (Minneapolis MN) Coury Arthur J. (St. Paul MN) Doan Phong D. (Shoreview MN) Sandstrom Richard D. (Scandia MN), Medical electrical lead with polymeric monolithic controlled release device and method of manufacture.
Eisen Drore (6720 E. Beechlands Dr. Cincinnati OH 65237), Method of treatment using mouthwashes containing steroids and antifungal agents and compositions of matter.
Garlich Joseph R. (Lake Jackson TX) Masterson Tipton T. (Lake Jackson TX) Simon Jaime (Angleton TX) Hegde Vidyadhar B. (Indianapolis IN), Oral compositions for suppressing mouth odors.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.